No Data
No Data
Xiaofang Pharmaceutical (603207.SH): The stock will be listed on the main board of the Shanghai Stock Exchange on August 26th.
Gelonghui August 22nd| Xiaofang Pharmaceutical (603207.SH) announced that the company's stocks will be listed on the main board of the Shanghai Stock Exchange on August 26, 2024.
Xiaofang Pharmaceuticals (603207.SH): The final online subscription rate is 0.0478%.
On August 15, Gelunhui reported that Xiaofang Pharmaceuticals (603207.SH) announced that after the callback mechanism was initiated, the final number of shares issued to offline investors was 8 million, accounting for 20.00% of the total issued shares, while the final number of shares issued to online investors was 32 million, accounting for 80.00% of the total issued shares. After the callback mechanism was initiated, the final winning rate for online issuance was 0.04782820%.
A Share Subscription | Xiao Fang Pharmaceutical (603207.SH) started the subscription. The brand has various external use products such as Kaisailu and Lugen Stone lotion.
On August 15th, Xiaofang Pharmaceuticals (603207.SH) began its subscription.
Xiaofang Pharmaceutical (603207.SH) has set an IPO price of 12.47 yuan/share and will start subscription on August 15th.
Xiaofang Pharmaceutical (603207.SH) announced that the issuer and the sponsor (lead underwriter) have determined the price range based on the preliminary inquiry results...
Shanghai Xiao Fang Pharmaceutical to Offer 40 Million Shares in Shanghai IPO
Xiaofang Pharmaceuticals (603207.SH), which focuses on the research and development, production, and sales of topical drugs, plans to publicly issue 40 million shares for the first time.
Xiaofang Pharmaceutical (603207.SH) has disclosed its IPO prospectus, with the company planning to issue 40 million stocks this time...
No Data